OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

@inproceedings{Ginsberg2013OnabotulinumtoxinAIE,
  title={OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology},
  author={David A Ginsberg and Francisco J. G{\'o}mez-de la Cruz and Sender Herschorn and Angelo E. Gousse and Veronique D. Keppenne and Philip J Aliotta and Karl-Dietrich Sievert and Mitchell F. Brin and Brenda Jenkins and Catherine Thompson and Wayne Lam and John P F A Heesakkers and Cornelia Haag-Molkenteller},
  booktitle={Advances in therapy},
  year={2013}
}
INTRODUCTION To evaluate the efficacy and safety of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity (NDO) in subpopulations of etiology (multiple sclerosis [MS] or spinal cord injury [SCI]) and concomitant anticholinergics (use/non-use). METHODS Data were pooled from two double-blind, placebo-controlled, pivotal, phase 3 studies including a total of 691 patients with ≥ 14 urinary incontinence (UI) episodes/week due to MS (n = 381) or SCI (n = 310). Patients received… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Similar Papers

Loading similar papers…